ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0529

Complex Relationships Between Inflammation and Clonal Hematopoiesis in Systemic Vasculitis

Adrianna Jones1, Kristina Wells1, Fernanda Gutierrez-Rodrigues2, Cameron Rankin3, Wanxia Tsai3, Bhavisha Patel4, Kaitlin Quinn1, Dalton Hironaka2, Massimo Gadina5, Keith Sikora1, Neal Young2 and Peter Grayson6, 1National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), National Institutes of Health (NIH), Bethesda, MD, 2National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health (NIH), Bethesda, MD, 3NIAMS/NIH, Bethesda, MD, 4National Institutes of Health, Beltsville, MD, 5Translational Immunology Section, NIAMS, NIH, Bethesda, MD, 6National Institutes of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), National Institutes of Health (NIH), Bethesda, MD

Meeting: ACR Convergence 2022

Keywords: Aging, macrophages, Vasculitis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Saturday, November 12, 2022

Title: Abstracts: Vasculitis – ANCA-Associated

Session Type: Abstract Session

Session Time: 3:00PM-4:30PM

Background/Purpose: Clonal hematopoiesis of indeterminate potential (CHIP) is defined by somatic mutations in a set of genes commonly associated with myeloid neoplasms in an otherwise healthy individual. CHIP prevalence increases with age and is associated with all-cause mortality and atherosclerosis. The prevalence of CHIP mutations in systemic vasculitis and other inflammatory diseases has not been well characterized. We examined the prevalence of CHIP in systemic vasculitis across the age spectrum and uncovered functional consequences of CHIP mutations in vasculitis.

Methods: DNA from peripheral whole blood and isolated monocytes was sequenced on an error-correcting targeted sequencing panel to identify clonal hematopoiesis mutations (VAF≥0.5%). Logistic regression was used to assess associations of age, vasculitis, and CHIP. Relative contribution of predictor variables was assessed using standardized beta coefficients. Monocytes were isolated from patients with giant cell arteritis (GCA) and healthy control PBMCs via CD14 magnetic bead separation and stimulated with combinations of IFNg, LPS, and ATP. Cytokine and chemokine expression in the cell culture supernatant was measured via multiplex analysis.

Results: 171 patients with vasculitis [Takayasu’s arteritis, TAK: n=70; mean age=33.7 years; ANCA-associated vasculitis, AAV: n=47; mean age=55.3 years; GCA: n=54; mean age=70.2 years), and age-matched healthy controls (n=120) were studied. CHIP mutations were prevalent in 58% of GCA, 36% of AAV, and 15% of TAK compared to 32%, 23% and 8% of 1:1 age-matched healthy controls for each disease, respectively. Age (b=0.96, p< 0.001) and vasculitis (b=0.46, p=0.004) were independently associated with CHIP. The most common affected genes were DNMT3A (n=69/109,63%) and TET2 (n=19/109,17%). Vasculitis patients with CHIP had lower circulating absolute lymphocyte counts (p=0.03) and higher absolute neutrophil counts (p=0.04) than those without CHIP. The neutrophil-to-lymphocyte ratio was significantly associated with presence of CHIP (p=0.02). Compared to stimulation of CHIP- monocytes, stimulated CHIP+ monocytes had significantly increased expression of IL-8 (LPS+IFNg (p=0.048)), IL-27 (LPS+IFNg (p=0.016)) and CXCL10 (LPS+IFNg (p=0.016)) in monocytes with a VAF of 2.0% or higher and increased expression of TNFa (LPS+IFNg (p=0.012)), MIP-1a (LPS (p=0.034), LPS+IFNg (p=0.012)) and CCL2 (IFNg (p=0.021)) regardless of VAF.

Conclusion: Vasculitis and age are independently associated with CHIP. Peripheral blood from CHIP+ vasculitis patients skews towards myeloid lineages. Monocytes harboring CHIP mutations secrete more CCL2 and CXCL10 when stimulated, which are important chemokines in vascular disease. Inflammation is both a cause and consequence of CHIP.


Disclosures: A. Jones, None; K. Wells, None; F. Gutierrez-Rodrigues, None; C. Rankin, None; W. Tsai, None; B. Patel, None; K. Quinn, None; D. Hironaka, None; M. Gadina, None; K. Sikora, None; N. Young, None; P. Grayson, None.

To cite this abstract in AMA style:

Jones A, Wells K, Gutierrez-Rodrigues F, Rankin C, Tsai W, Patel B, Quinn K, Hironaka D, Gadina M, Sikora K, Young N, Grayson P. Complex Relationships Between Inflammation and Clonal Hematopoiesis in Systemic Vasculitis [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/complex-relationships-between-inflammation-and-clonal-hematopoiesis-in-systemic-vasculitis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/complex-relationships-between-inflammation-and-clonal-hematopoiesis-in-systemic-vasculitis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology